Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Allena slips after pricing $74.7M IPO

November 2, 2017 3:10 PM UTC

Allena Pharmaceuticals Inc. (NASDAQ:ALNA) dipped $4.02 (29%) to $9.98 on Thursday after it raised $74.7 million through the sale of 5.3 million shares at $14 in an IPO underwritten by Credit Suisse, Jefferies, Cowen and Wedbush PacGrow. The price valued Allena at $288.7 million.

Allena priced the offering at the bottom of its proposed range. Last month, Allena hoped to sell 5.3 million shares at $14-$16. At the $15 midpoint, it would have raised $80 million and been valued at $309.3 million. Allena originally proposed to raise $92 million (see BioCentury Extra, Oct. 9)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Allena Pharmaceuticals Inc.